HIV transmission: Time for translational studies to bridge the gap

Science Translational Medicine

Volumn 3, Issue 77, 2011, Pages

  Anton, Peter ^a   Herold, Betsy C ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; PLACEBO; TENOFOVIR; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CIRCUMCISION; DISEASE TRANSMISSION; DRUG EFFICACY; DRUG SAFETY; GENETIC VARIABILITY; GENITAL SYSTEM; HETEROSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INNATE IMMUNITY; LANGERHANS CELL; LEUKOCYTE; LIFESPAN; NONHUMAN; PATIENT CARE; PHARMACODYNAMICS; PRIORITY JOURNAL; REVIEW; SEQUENCE ANALYSIS; SEXUAL BEHAVIOR; SEXUAL TRANSMISSION; TRANSLATIONAL RESEARCH; TREATMENT RESPONSE; VAGINA DISCHARGE; VIRUS LOAD; VIRUS SHEDDING; ARTICLE; FEMALE; FEMALE GENITAL SYSTEM; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PHYSIOLOGY; VIROLOGY;

FEMALE; GENITALIA, FEMALE; HETEROSEXUALITY; HIV INFECTIONS; HUMANS; MALE;

EID: 79953887424     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3002329     Document Type: Review

References (43)

1. J. M. Baeten, E. Kahle, J. R. Lingappa, R. W. Coombs, S. Delany-Moretlwe, E. Nakku-Joloba, N. R. Mugo, A. Wald, L. Corey, D. Donnell, M. S. Campbell, J. I. Mullins, C. Celum, Genital HIV-1 RNA predicts risk of heterosexual HIV-1 transmission. Sci. Transl. Med. 3, 77ra29 (2011).
2. M. S. Cohen, C. L. Gay, M. P. Busch, F. M. Hecht, The detection of acute HIV infection. J. Infect. Dis. 202 (suppl. 2), S270-S277 (2010).
3. M. S. Cohen, C. L. Gay, Treatment to prevent transmission of HIV-1. Clin. Infect. Dis. 50 (suppl. 3), S85-S95 (2010).
4. T. C. Quinn, Circumcision and HIV transmission. Curr. Opin. Infect. Dis. 20, 33-38 (2007).
5. B. Auvert, D. Taljaard, E. Lagarde, J. Sobngwi-Tambekou, R. Sitta, A. Puren, Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med. 2, e298 (2005).
6. R. H. Gray, G. Kigozi, D. Serwadda, F. Makumbi, S. Watya, F. Nalugoda, N. Kiwanuka, L. H. Moulton, M. A. Chaudhary, M. Z. Chen, N. K. Sewankambo, F. Wabwire-Mangen, M. C. Bacon, C. F. Williams, P. Opendi, S. J. Reynolds, O. Laeyendecker, T. C. Quinn, M. J. Wawer, Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet 369, 657-666 (2007).
7. R. C. Bailey, S. Moses, C. B. Parker, K. Agot, I. Maclean, J. N. Krieger, C. F. Williams, R. T. Campbell, J. O. Ndinya-Achola, Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet 369, 643-656 (2007).
8. Q. Abdool Karim, S. S. Abdool Karim, J. A. Frohlich, A. C. Grobler, C. Baxter, L. E. Mansoor, A. B. Kharsany, S. Sibeko, K. P. Mlisana, Z. Omar, T. N. Gengiah, S. Maarschalk, N. Arulappan, M. Mlotshwa, L. Morris, D. Taylor on behalf of the CAPRISA 004 Trial Group, Eff ectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 329, 1168-1174 (2010).
9. R. M. Grant, J. R. Lama, P. L. Anderson, V. McMahan, A. Y. Liu, L. Vargas, P. Goicochea, M. Casapía, J. V. Guanira-Carranza, M. E. Ramirez-Cardich, O. Montoya-Herrera, T. Fernández, V. G. Veloso, S. P. Buchbinder, S. Chariyalertsak, M. Schechter, L. G. Bekker, K. H. Mayer, E. G. Kallás, K. R. Amico, K. Mulligan, L. R. Bushman, R. J. Hance, C. Ganoza, P. Defechereux, B. Postle, F. Wang, J. J. McConnell, J. H. Zheng, J. Lee, J. F. Rooney, H. S. Jaffe, A. I. Martinez, D. N. Burns, D. V. Gliddeni for the PrEx Study Team, Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N. Engl. J. Med. 363, 2587-2599 (2010).
10. V. Supervie, J. G. García-Lerma, W. Heneine, S. Blower, HIV, transmitted drug resistance, and the paradox of preexposure prophylaxis. Proc. Natl. Acad. Sci. U.S.A. 107, 12381-12386 (2010).
11. D. P. Wilson, P. M. Coplan, M. A. Wainberg, S. M. Blower, The paradoxical eff ects of using antiretroviral-based microbicides to control HIV epidemics. Proc. Natl. Acad. Sci. U.S.A. 105, 9835-9840 (2008).
12. R. Breban, I. M. McGowan, C. Topaz, E. J. Schwartz, P. Anton, S. Blower, Modeling the potential impact of rectal microbicides to reduce hiv transmission in bathhouses. Math. Biosci. Eng. 3, 459-466 (2006).
13. R. K. Malcolm, K. L. Edwards, P. Kiser, J. Romano, T. J. Smith, Advances in microbicide vaginal rings. Antiviral Res. 88, (Suppl 1), S30-S39 (2010).
14. G. J. Hughes, E. Fearnhill, D. Dunn, S. J. Lycett, A. Rambaut, A. J. Leigh Brown on behalf of the UK HIV Drug Resistance Collaboration, Molecular phylodynamics of the heterosexual HIV epidemic in the United Kingdom. PLoS Pathog. 5, e1000590 (2009).
15. P. A. Anton, J. Elliott, M. A. Poles, I. M. McGowan, J. Matud, L. E. Hultin, K. Grovit-Ferbas, C. R. Mackay, I. S. Y. Chen, J. V. Giorgi, Enhanced levels of functional HIV-1 co-receptors on human mucosal T cells demonstrated using intestinal biopsy tissue. AIDS 14, 1761-1765 (2000).
16. I. McGowan, J. Elliott, G. Cortina, K. Tanner, C. Siboliban, A. Adler, D. Cho, W. J. Boscardin, L. Soto-Torres, P. A. Anton, Characterization of baseline intestinal mucosal indices of injury and infl ammation in men for use in rectal microbicide trials (HIV Prevention Trials Network-056). J. Acquir. Immune Defic. Syndr. 46, 417-425 (2007).
17. Centers for Disease Control and Prevention (CDC), Interim guidance: preexposure prophylaxis for the prevention of HIV infection in men who have sex with men. MMWR Morb. Mortal. Wkly. Rep. 60, 65-68 (2011).
18. G. M. Myers, K. H. Mayer, Oral preexposure anti-HIV prophylaxis for high-risk U.S. populations: Current considerations in light of new findings. AIDS Patient Care STDS 25, 63-71 (2011).
19. R. A. Zuckerman, W. L. Whittington, C. L. Celum, T. K. Collis, A. J. Lucchetti, J. L. Sanchez, J. P. Hughes, J. L. Sanchez, R. W. Coombs, Higher concentration of HIV RNA in rectal mucosa secretions than in blood and seminal plasma, among men who have sex with men, independent of antiretroviral therapy. J. Infect. Dis. 190, 156-161 (2004).
20. D. N. Burns, C. W. Dieffenbach, S. H. Vermund, Rethinking prevention of HIV type 1 infection. Clin. Infect. Dis. 51, 725-731 (2010).
21. J. A. Anderson, L. H. Ping, O. Dibben, C. B. Jabara, L. Arney, L. Kincer, Y. Tang, M. Hobbs, I. Hoffman, P. Kazembe, C. D. Jones, P. Borrow, S. Fiscus, M. S. Cohen, R. Swanstrom, HIV-1 populations in semen arise through multiple mechanisms. PLoS Pathog. 6, e1001053 (2010).
22. J. Del Romero, J. Castilla, V. Hernando, C. Rodríguez, S. García, Combined antiretroviral treatment and heterosexual transmission of HIV-1: cross sectional and prospective cohort study. BMJ 340, c2205 (2010).
23. J. R. Lingappa, J. P. Hughes, R. S. Wang, J. M. Baeten, C. Celum, G. E. Gray, W. S. Stevens, D. Donnell, M. S. Campbell, C. Farquhar, M. Essex, J. I. Mullins, R. W. Coombs, H. Rees, L. Corey, A. Wald for the Partners in Prevention HSV/HIV Transmission Study Team, Estimating the impact of plasma HIV-1 RNA reductions on heterosexual HIV-1 transmission risk. PLoS ONE 5, e12598 (2010).
24. W. A. Were, J. H. Mermin, N. Wamai, A. C. Awor, S. Bechange, S. Moss, P. Solberg, R. G. Downing, A. Coutinho, R. E. Bunnell, Undiagnosed HIV infection and couple HIV discordance among household members of HIV-infected people receiving antiretroviral therapy in Uganda. J. Acquir. Immune Defic. Syndr. 43, 91-95 (2006).
25. E. M. Gardner, M. P. McLees, J. F. Steiner, C. Del Rio, W. J. Burman, The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin. Infect. Dis. 52, 793-800 (2011).
26. S. Cu-Uvin, A. K. DeLong, K. K. Venkatesh, J. W. Hogan, J. Ingersoll, J. Kurpewski, M. P. De Pasquale, R. D'Aquila, A. M. Caliendo, Genital tract HIV-1 RNA shedding among women with below detectable plasma viral load. AIDS 24, 2489-2497 (2010).
27. S. Patel, E. Hazrati, N. Cheshenko, B. Galen, H. Yang, E. Guzman, R. Wang, B. C. Herold, M. J. Keller, Seminal plasma reduces the eff ectiveness of topical polyanionic microbicides. J. Infect. Dis. 196, 1394-1402 (2007).
28. M. J. Keller, P. M. Mesquita, N. M. Torres, S. Cho, G. Shust, R. P. Madan, H. W. Cohen, J. Petrie, T. Ford, L. Soto-Torres, A. T. Profy, B. C. Herold, Postcoital bioavailability and antiviral activity of 0.5% PRO 2000 gel: implications for future microbicide clinical trials. PLoS ONE 5, e8781 (2010).
29. C. W. Hendrix, E. J. Fuchs, K. J. Macura, L. A. Lee, T. L. Parsons, R. P. Bakshi, W. A. Khan, A. Guidos, J. P. Leal, R. Wahl, Quantitative imaging and sigmoidoscopy to assess distribution of rectal microbicide surrogates. Clin. Pharmacol. Ther. 83, 97-105 (2008).
30. J. Münch, E. Rücker, L. Ständker, K. Adermann, C. Goffinet, M. Schindler, S. Wildum, R. Chinnadurai, D. Rajan, A. Specht, G. Giménez-Gallego, P. C. Sánchez, D. M. Fowler, A. Koulov, J. W. Kelly, W. Mothes, J. C. Grivel, L. Margolis, O. T. Keppler, W. G. Forssmann, F. Kirchhoff , Semen-derived amyloid fi brils drastically enhance HIV infection. Cell 131, 1059-1071 (2007).
31. D. J. Sharkey, A. M. Macpherson, K. P. Tremellen, S. A. Robertson, Seminal plasma diff erentially regulates infl ammatory cytokine gene expression in human cervical and vaginal epithelial cells. Mol. Hum. Reprod. 13, 491-501 (2007).
32. W. Berlier, M. Cremel, H. Hamzeh, R. Lévy, F. Lucht, T. Bourlet, B. Pozzetto, O. Delézay, Seminal plasma promotes the attraction of Langerhans cells via the secretion of CCL20 by vaginal epithelial cells: involvement in the sexual transmission of HIV. Hum. Reprod. 21, 1135-1142 (2006).
33. C. J. Miller, Q. Li, K. Abel, E.-Y. Kim, Z. M. Ma, S. Wietgrefe, L. La Franco-Scheuch, L. Compton, L. Duan, M. D. Shore, M. Zupancic, M. Busch, J. Carlis, S. Wolinsky, A. T. Haase, Propagation and dissemination of infection after vaginal transmission of simian immunodefi ciency virus. J. Virol. 79, 9217-9227 (2005).
34. C. Celum, A. Wald, J. R. Lingappa, A. S. Magaret, R. S. Wang, N. Mugo, A. Mujugira, J. M. Baeten, J. I. Mullins, J. P. Hughes, E. A. Bukusi, C. R. Cohen, E. Katabira, A. Ronald, J. Kiarie, C. Farquhar, G. J. Stewart, J. Makhema, M. Essex, E. Were, K. H. Fife, G. de Bruyn, G. E. Gray, J. A. McIntyre, R. Manongi, S. Kapiga, D. Coetzee, S. Allen, M. Inambao, K. Kayitenkore, E. Karita, W. Kanweka, S. Delany, H. Rees, B. Vwalika, W. Stevens, M. S. Campbell, K. K. Thomas, R. W. Coombs, R. Morrow, W. L. Whittington, M. J. McElrath, L. Barnes, R. Ridzon, L. Corey for the Partners in Prevention HSV/HIV Transmission Study Team, Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. N. Engl. J. Med. 362, 427-439 (2010).
35. M. S. Campbell, J. I. Mullins, J. P. Hughes, C. Celum, K. G. Wong, D. N. Raugi, S. Sorensen, J. N. Stoddard, H. Zhao, W. Deng, E. Kahle, D. Panteleeff , J. M. Baeten, F. E. McCutchan, J. Albert, T. Leitner, A. Wald, L. Corey, J. R. Lingappa for the Partners in Prevention HSV/HIV Transmission Study Team, Viral linkage in HIV-1 seroconverters and their partners in an HIV-1 prevention clinical trial. PLoS ONE 6, e16986 (2011).
36. F. H. Priddy, S. Wakasiaka, T. D. Hoang, D. J. Smith, B. Farah, C. Del Rio, J. O. Ndinya-Achola, Anal sex, vaginal practices and HIV incidence in female sex workers in urban Kenya: Implications for development of intravaginal HIV prevention methods. AIDS Res. Hum. Retroviruses 110315234300054 (2011).
37. K. E. Mark, A. Wald, A. S. Magaret, S. Selke, L. Olin, M. L. Huang, L. Corey, Rapidly cleared episodes of herpes simplex virus reactivation in immunocompetent adults. J. Infect. Dis. 198, 1141-1149 (2008).
38. K. E. Mark, A. Wald, A. S. Magaret, S. Selke, S. Kuntz, M. L. Huang, L. Corey, Rapidly cleared episodes of oral and anogenital herpes simplex virus shedding in HIV-infected adults. J. Acquir. Immune Defic. Syndr. 54, 482-488 (2010).
39. R. H. Gray, M. J. Wawer, Reassessing the hypothesis on STI control for HIV prevention. Lancet 371, 2064-2065 (2008).
40. C. Tanton, H. A. Weiss, J. Le Goff , J. Changalucha, M. Rusizoka, K. Baisley, D. Everett, D. A. Ross, L. Belec, R. J. Hayes, D. Watson-Jones, Correlates of HIV-1 genital shedding in Tanzanian women. PLoS ONE 6, e17480 (2011).
41. E. J. Fuchs, L. A. Lee, M. S. Torbenson, T. L. Parsons, R. P. Bakshi, A. M. Guidos, R. L. Wahl, C. W. Hendrix, Hyperosmolar sexual lubricant causes epithelial damage in the distal colon: potential implication for HIV transmission. J. Infect. Dis. 195, 703-710 (2007).
42. E. Fakioglu, S. S. Wilson, P. M. Mesquita, E. Hazrati, N. Cheshenko, J. A. Blaho, B. C. Herold, Herpes simplex virus downregulates secretory leukocyte protease inhibitor: a novel immune evasion mechanism. J. Virol. 82, 9337-9344 (2008).
43. Funding: B.C.H. is supported by U.S. National Institutes of Health (NIH) grants AI076980, AI065309, AI079763, and AI069551 and the Center for AIDS Research at the Albert Einstein College of Medicine and Montefi ore Medical Center (NIH grant AI-51519). P.A. is supported by NIH grants AI060614, AI082637, AI086182, AG032422, and AI28697 and by the UCLA Center for AIDS Research Mucosal Immunology Core. Competing interests: The authors declare no competing interests.